Scinai Immunotherapeutics Ltd. (SCNI)
1.18
-0.03
(-2.48%)
USD |
NASDAQ |
Oct 09, 16:00
1.195
+0.02
(+1.27%)
After-Hours: 20:00
Scinai Immunotherapeutics Enterprise Value : 7.027M for Oct. 9, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 7.027M |
| October 08, 2026 | 7.044M |
| October 07, 2026 | 6.998M |
| October 06, 2026 | 7.049M |
| October 05, 2026 | 7.072M |
| October 02, 2026 | 7.112M |
| October 01, 2026 | 7.101M |
| September 30, 2026 | 7.163M |
| September 29, 2026 | 7.158M |
| September 28, 2026 | 7.192M |
| September 25, 2026 | 7.238M |
| September 24, 2026 | 7.414M |
| September 23, 2026 | 7.483M |
| September 22, 2026 | 7.443M |
| September 21, 2026 | 7.317M |
| September 18, 2026 | 7.243M |
| September 17, 2026 | 7.277M |
| September 16, 2026 | 7.220M |
| September 15, 2026 | 7.232M |
| September 14, 2026 | 7.745M |
| September 11, 2026 | 7.300M |
| September 10, 2026 | 7.306M |
| September 09, 2026 | 7.329M |
| September 08, 2026 | 7.323M |
| September 04, 2026 | 7.414M |
| Date | Value |
|---|---|
| September 03, 2026 | 7.466M |
| September 02, 2026 | 7.688M |
| September 01, 2026 | 7.756M |
| August 31, 2026 | 7.779M |
| August 28, 2026 | 7.785M |
| August 27, 2026 | 7.882M |
| August 26, 2026 | 7.990M |
| August 25, 2026 | 7.996M |
| August 24, 2026 | 8.138M |
| August 21, 2026 | 8.189M |
| August 20, 2026 | 8.030M |
| August 19, 2026 | 7.916M |
| August 18, 2026 | 7.696M |
| August 17, 2026 | 7.655M |
| August 14, 2026 | 7.736M |
| August 13, 2026 | 7.722M |
| August 12, 2026 | 7.762M |
| August 11, 2026 | 7.699M |
| August 10, 2026 | 7.786M |
| August 07, 2026 | 7.752M |
| August 06, 2026 | 7.829M |
| August 05, 2026 | 7.779M |
| August 04, 2026 | 7.780M |
| August 03, 2026 | 7.910M |
| July 31, 2026 | 7.910M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Compugen Ltd. | 79.49M |
| Pluri, Inc. | 43.00M |
| Evogene Ltd. | 6.981M |
| CollPlant Biotechnologies Ltd. | 4.779M |
| Regentis Biomaterials Ltd. | 53.61M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.037M |
| Revenue (Quarterly) | 0.4679M |
| Total Expenses (Quarterly) | 2.505M |
| EPS Diluted (Quarterly) | -3.662 |
| Gross Profit Margin (Quarterly) | -272.2% |
| Profit Margin (Quarterly) | -435.4% |
| Earnings Yield | -37.50K% |
| Normalized Earnings Yield | -18452.97 |